Melvin Helm
Neurology · Fresno, CANPI 1124076211
Payments from drug & device makers
Across 823 payments — averaging $1338.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$968K
- Lilly USA, LLC$44K
- Teva Pharmaceuticals USA, Inc.$37K
- Biohaven Pharmaceuticals, Inc.$23K
- Amgen$18K
- Eli Lilly$6K
- plus $6K from 26 others
Across 2 payments — averaging $6412.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$13K
What the payments were for
- Consulting fees$5,9013%
- Speaking & faculty fees$181,70089%
- Travel & lodging$4,5432%
- Food & beverage$11,2466%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 314 | $968,253 |
| Lilly USA, LLC | 62 | $43,610 |
| Teva Pharmaceuticals USA, Inc. | 83 | $36,818 |
| Biohaven Pharmaceuticals, Inc. | 46 | $22,815 |
| Amgen | 51 | $18,041 |
| Eli Lilly | 1 | $6,250 |
| Lundbeck LLC | 15 | $2,556 |
| Novartis | 61 | $552 |
| Sunovion Pharmaceuticals Inc. | 36 | $300 |
| UCB, Inc. | 13 | $290 |
| Zyla Life Sciences, Inc. | 27 | $286 |
| Amneal Pharmaceuticals LLC | 17 | $269 |
| Acadia Pharmaceuticals Inc | 12 | $266 |
| Supernus Pharmaceuticals, Inc. | 23 | $254 |
| Upsher-smith Laboratories LLC | 13 | $246 |
| EMD Serono, Inc. | 7 | $180 |
| Assertio Therapeutics, Inc. | 12 | $146 |
| Neuronetics, Inc. | 4 | $117 |
| Almatica Pharma LLC | 3 | $65 |
| Arbor Pharmaceuticals, Inc. | 3 | $46 |
| Acorda Therapeutics, Inc | 3 | $45 |
| Biogen | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 3 | $41 |
| Akcea Therapeutics, Inc. | 2 | $32 |
| Bristol Myers Squibb | 2 | $27 |
| Eisai Inc. | 2 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| SK Life Science, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,101,662 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Other neurology in Fresno
- Perminder BhatiaFresno$8.3M
- Timothy CloughesyLos Angeles$33.1M
- Jack FlorinFullerton$13M
- David KudrowSanta Monica$12.8M
- John Ravitsla Jolla$8.4M
- Perry ShiehLos Angeles$8.2M
- Benjamin FrishbergCarlsbad$8.2M
- Bruce CreeSan Francisco$8M
- Lawrence RechtPalo Alto$6.6M
- Stanley PrusinerSan Francisco$6.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.